Cargando…

Risk for cognitive impairment among HIV-infected persons with bipolar disorder

Clinicians and clinical neuroscientists are aware that individuals with bipolar disorder are at greater risk for developing serious medical, psychiatric, and substance-use comorbidities as compared with the general population.(1,2) Less widely appreciated, however, is the observation that HIV infect...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, David J., Depp, Colin A., Posada, Carolina, Parikh, Mili, Bhatt, Archana, Moseley, Suzanne, Vigil MS, Ofilio, Everall, Ian P., Atkinson, J. Hampton, Grant, Igor, HNRC Group
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Les Laboratoires Servier 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181874/
_version_ 1782212831710543872
author Moore, David J.
Depp, Colin A.
Posada, Carolina
Parikh, Mili
Bhatt, Archana
Moseley, Suzanne
Vigil MS, Ofilio
Everall, Ian P.
Atkinson, J. Hampton
Grant, Igor
HNRC Group,
author_facet Moore, David J.
Depp, Colin A.
Posada, Carolina
Parikh, Mili
Bhatt, Archana
Moseley, Suzanne
Vigil MS, Ofilio
Everall, Ian P.
Atkinson, J. Hampton
Grant, Igor
HNRC Group,
author_sort Moore, David J.
collection PubMed
description Clinicians and clinical neuroscientists are aware that individuals with bipolar disorder are at greater risk for developing serious medical, psychiatric, and substance-use comorbidities as compared with the general population.(1,2) Less widely appreciated, however, is the observation that HIV infection appears to be more prevalent among persons with bipolar disorder and that both conditions pose significant risk for cognitive impairment.(3) Higher rates of HIV infection among persons with bipolar disorder should not be surprising, given that infection and transmission of HIV involves risk factors that converge with bipolar disorder (eg, impulsivity, substance abuse). These factors likely also worsen adherence to treatment for both bipolar and HIV illness, and may adversely impact health-related quality of life and therapeutic outcomes. The public health consequence may be that nonadherence to antiretroviral therapy could lead to higher rates of transmission of treatment-resistant strains of HIV that can evolve with sporadic adherence. The intersection of bipolar disorder and HIV therefore merits discussion by clinicians, researchers, and policy makers.
format Online
Article
Text
id pubmed-3181874
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Les Laboratoires Servier
record_format MEDLINE/PubMed
spelling pubmed-31818742011-10-27 Risk for cognitive impairment among HIV-infected persons with bipolar disorder Moore, David J. Depp, Colin A. Posada, Carolina Parikh, Mili Bhatt, Archana Moseley, Suzanne Vigil MS, Ofilio Everall, Ian P. Atkinson, J. Hampton Grant, Igor HNRC Group, Dialogues Clin Neurosci Poster Clinicians and clinical neuroscientists are aware that individuals with bipolar disorder are at greater risk for developing serious medical, psychiatric, and substance-use comorbidities as compared with the general population.(1,2) Less widely appreciated, however, is the observation that HIV infection appears to be more prevalent among persons with bipolar disorder and that both conditions pose significant risk for cognitive impairment.(3) Higher rates of HIV infection among persons with bipolar disorder should not be surprising, given that infection and transmission of HIV involves risk factors that converge with bipolar disorder (eg, impulsivity, substance abuse). These factors likely also worsen adherence to treatment for both bipolar and HIV illness, and may adversely impact health-related quality of life and therapeutic outcomes. The public health consequence may be that nonadherence to antiretroviral therapy could lead to higher rates of transmission of treatment-resistant strains of HIV that can evolve with sporadic adherence. The intersection of bipolar disorder and HIV therefore merits discussion by clinicians, researchers, and policy makers. Les Laboratoires Servier 2008-06 /pmc/articles/PMC3181874/ Text en Copyright: © 2008 LLS http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster
Moore, David J.
Depp, Colin A.
Posada, Carolina
Parikh, Mili
Bhatt, Archana
Moseley, Suzanne
Vigil MS, Ofilio
Everall, Ian P.
Atkinson, J. Hampton
Grant, Igor
HNRC Group,
Risk for cognitive impairment among HIV-infected persons with bipolar disorder
title Risk for cognitive impairment among HIV-infected persons with bipolar disorder
title_full Risk for cognitive impairment among HIV-infected persons with bipolar disorder
title_fullStr Risk for cognitive impairment among HIV-infected persons with bipolar disorder
title_full_unstemmed Risk for cognitive impairment among HIV-infected persons with bipolar disorder
title_short Risk for cognitive impairment among HIV-infected persons with bipolar disorder
title_sort risk for cognitive impairment among hiv-infected persons with bipolar disorder
topic Poster
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181874/
work_keys_str_mv AT mooredavidj riskforcognitiveimpairmentamonghivinfectedpersonswithbipolardisorder
AT deppcolina riskforcognitiveimpairmentamonghivinfectedpersonswithbipolardisorder
AT posadacarolina riskforcognitiveimpairmentamonghivinfectedpersonswithbipolardisorder
AT parikhmili riskforcognitiveimpairmentamonghivinfectedpersonswithbipolardisorder
AT bhattarchana riskforcognitiveimpairmentamonghivinfectedpersonswithbipolardisorder
AT moseleysuzanne riskforcognitiveimpairmentamonghivinfectedpersonswithbipolardisorder
AT vigilmsofilio riskforcognitiveimpairmentamonghivinfectedpersonswithbipolardisorder
AT everallianp riskforcognitiveimpairmentamonghivinfectedpersonswithbipolardisorder
AT atkinsonjhampton riskforcognitiveimpairmentamonghivinfectedpersonswithbipolardisorder
AT grantigor riskforcognitiveimpairmentamonghivinfectedpersonswithbipolardisorder
AT hnrcgroup riskforcognitiveimpairmentamonghivinfectedpersonswithbipolardisorder